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Abstract 
Red blood cell hemodynamics influence blood rheology and thus circulatory function. 
Different authors showed that red blood cells are heterogeneous in blood flow. This 
heterogeneity could be explained by physical characteristics such as morphology, 
aggregability and deformability, but also by cellular and molecular environment. All 
these notions are found in sickle cell disease where sickle red blood cells become more 
rigid, leading to vascular occlusions, increased with an inflammatory context. 
In a preceding study, our results showed that velocity heterogeneity allow RBC 
classification, leading to different RBC sub-groups, using a dynamical approach and 
flow studies. In order to have a better understanding of the physiological meaning of 
such an heterogeneity, dynamical velocity experiences have been conducted in the case 
of normal and sickle red blood cells with different endothelial activations by 
proinflammatory cytokines, under a constant venular flow. 
Thus, normal and sickle red blood cells are classified into different sub-groups, showing 
their heterogeneity. Moreover, sub-population velocities and distribution evolve 
differently according to vascular state or treatment. 
These results show that red blood cell velocities and rheology depend on vascular 
environment and red blood cell morphology. However, the physiological meaning of 
this behavior should be explained by cellular and molecular effects of such activation. 
 
Keywords: Adhesion; Blood flow; Hemodynamics; Sickle red blood cell; Velocity. 
Abbreviations: EC, endothelial cell; HAC; hierarchical agglomerative clustering; MV, 
mean velocity; RBC, red blood cell; TrHBMEC, transformed human bone marrow 
endothelial cells 
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1. Introduction 
 
Dynamics of the vascular system imply many notions such as fluid dynamic problems, 
interaction between blood flow, blood elements, vessels and vascular tissues or 
mathematical modeling (Li, 2006). Blood elements such as red blood cells (RBCs), may 
play an important role in vascular system dynamics and more generally, on circulatory 
function. Thus, RBC rheology may influence hemodynamics. 
RBC dynamics may be useful to understand this complex phenomenon. Some studies 
show that RBC population is heterogeneous according to their velocity in the 
circulatory system, particularly in venules (Rosenblum, 1971; Rosenblum, 1972a; 
Rosenblum, 1972b; Rosenblum, 1976). In addition, RBC characteristics such as age, 
density, cellular morphology and bio-chemical environment (Grima, 2007) may 
influence their behaviors in blood flow. 
RBC aggregation, known as ‘‘rouleaux’’, is fully reversible and disrupted by the shear 
forces that arise as the flow rate increases (Armstrong, Wenby, Meiselman, & Fisher, 
2004). It has also been hypothesized that the formation of aggregates of RBCs along the 
venular centerline (where low shear rates promote aggregation) may also enhance the 
radial migration of WBCs toward the EC as aggregates exclude WBCs from the axial 
core of RBCs (Pearson & Lipowsky, 2000). RBC aggregation is often significantly 
increased in disease states (Armstrong, Wenby, Meiselman, & Fisher, 2004; Bishop, 
Popel, Intaglietta, & Johnson, 2001; Hardwicke & Squire, 1952; Olshaker & Jerrard, 
1997). 
Moreover, previous studies have uncovered various findings related to the deformability 
of RBCs in a steady, uniform shear-flow field, such as RBC membrane changes, 
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hematocrit and intracellular viscosity (Fischer & Schmid-Schönbein, 1977; Fischer, 
Schmid-Schönbein, & Stöhr-Liesen, 1978a; Fischer, Stöhr, & Schmid-Schönbein, 
1978b; Kon, Maeda, & Shiga, 1987; Pfafferott, Nash, & Meiselman, 1985; Schmid-
Schönbein & Wells, 1969; Watanabe, Kataoka, Yasuda, & Takatani, 2006). 
It was clearly demonstrated that reductions in RBC deformability may adversely affect 
capillary perfusion (Driessen, Haest, Heidtmann, Kamp, & Schmid-Schönbein, 1980; 
Parthasarathi & Lipowsky, 1999). In addition, many diseases manifest reductions in 
RBC deformability. For example, elevated internal fluid viscosity or abnormal 
membrane stiffness was found in diabetes mellitus (Parthasarathi & Lipowsky, 1999; 
Schmid-Schönbein & Volger, 1976), a- and b-thalassemia (Parthasarathi & Lipowsky, 
1999; Schrier, Rachmilewitz, & Mohandas, 1989) and sickle cell disease (Parthasarathi 
& Lipowsky, 1999; Schmalzer, Manning, & Chien, 1989), particularly in 
microcirculation, where cell size is of the order of the blood vessel diameter (Bransky, 
Korin, Nemirovski, & Dinnar, 2007). Dynamic response and RBC behavior are also 
influenced by the nature of shear stress, uniform or reversing flow (Watanabe, Kataoka, 
Yasuda, & Takatani, 2006). 
RBC morphology, combined with cellular environment and vascular state, are two 
notions commonly found in Sickle Cell Disease, a specific disease. SS disease is a 
hemoglobinopathy caused by a mutation in the beta-globin gene (Glu6Val) (Ohene-
Frempong & Steinberg, 2001). Sickle hemoglobin molecules (HbS) have the property to 
polymerize when deoxygenated, forming sickle red blood cells (Ohene-Frempong & 
Steinberg, 2001). Rigid, deformed sickle red blood cells (SS RBCs) promote vascular 
occlusion, chronic ischemia-reperfusion injury, and episodic painful crises (Kato, 
Gladwin, & Steinberg, 2007; Ohene-Frempong & Steinberg, 2001; de Ceulaer, Higgs, 
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Weatherall, Hayes, Serjeant BE, & Serjeant GR, 1983). SS RBCs are proadhesive 
(Finnegan, Turhan, Golan, & Barabino, 2007; Hebbel, 1997; Wick & Eckman, 1996). 
Inflammatory mechanisms are thought to play a major role in the pathobiology of SS 
disease, probably via the endothelial inflammation (Finnegan, Turhan, Golan, & 
Barabino, 2007; Platt, 2000). 
Vaso-occlusive crisis are initiated by the adhesion reaction between the activated blood 
vessel endothelium and SS RBCs (Walmet, Eckman, & Wick, 2003). In addition, under 
flow conditions, reticulocytes were the most adherent of the heterogeneous population 
of sickle erythrocytes (Hebbel & Mohandas, 2001; Kato, Gladwin, & Steinberg, 2007). 
HbSS polymerization and adherence of SS RBCs to endothelium are thought to initiate 
sickle cell vasoocclusive pain episodes (Bunn, 1997; Hebbel, Boogaerts, Eaton, & 
Steinberg, 1980a; Hofrichter, Ross, & Eaton, 1974; Hoover, Rubin, Wise, & Warren, 
1979; Mozzarelli, Hofrichter, & Eaton, 1987; Wagner, Eckman, & Wick, 2004). 
Reticulocyte adherence provides an additional link between hemolytic anemia and 
sickle vaso-occlusion (Kato, Gladwin, & Steinberg, 2007). Sickle erythrocytes adhere to 
cultured endothelial cells and the tenacity of adherence reflects the severity of the 
disease (Hebbel, Boogaerts, Eaton, & Steinberg, 1980a; Hoover, Rubin, Wise, & 
Warren, 1979; Kato, Gladwin, & Steinberg, 2007). This abnormal adhesion is directly 
connected to the severity of the disease (Francis & Johnson, 1991; Hebbel, Boogaerts, 
Koresawa, Jacob, Eaton, & Steinberg, 1980b; Hebbel, 1991; Setty & Stuart, 1996). 
Vaso-oclusive process is very complex. This model has evolved from polymerization-
based concepts to a complex, wide-ranging schema that involves multistep, 
heterogeneous, and interdependent interactions among SS RBCs, adherent leukocytes, 
endothelial cells, plasma proteins, and other factors (Chiang & Frenette, 2005). 
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Endothelial activation, induced directly or indirectly by the proinflammatory behavior 
of SS RBCs, is the most likely initiating step toward vaso-occlusion (Chiang & 
Frenette, 2005). Previous studies demonstrated that sickle RBCs are more adherent to 
vascular endothelium and that the endothelium in sickle cell patients is inflamed (Duits 
et al., 1996; Solovey, Lin, Browne, Choong, & Wayner, 1997; Turhan, Jenab, Bruhns, 
Ravetch, Coller, & Frenette, 2004). Thus, sickle cell vaso-occlusion appears to involve 
multicellular interactions among RBCs, white blood cells, and the venular endothelium 
(Frenette, 2002; Turhan, Jenab, Bruhns, Ravetch, Coller, & Frenette, 2004). 
Moreover, transient sequestration of sickle RBCs in the low-flow state appears to be 
dominated by RBC / Endothelial cell (EC) adhesion, which becomes enhanced during 
crisis (Lipowsky & Williams, 1997). RBC adhesion would be predominant in post-
capillary venules (Chaudet, Renard, Seigneur, & Boisseau, 2000; Hebbel, Ney, & 
Foker, 1989; Hebbel, 1997; Kaul, Fabry, & Nagel, 1989; Montes, Eckman, Hsu, & 
Wick, 2002; Turitto, 1982). Although aggregation may enhance adhesive contact of 
RBCs with ECs, it does not increase to the same extent as the rate of sequestration, thus 
reflecting a greater role of RBC-EC adhesion (Lipowsky & Williams, 1997). In 
addition, RBC adhesion would be predominant in post-capillary venules with a 
physiological venular shear stress of 1 dyne/cm² (Kaul, Fabry, & Nagel, 1989; Montes, 
Eckman, Hsu, & Wick, 2002; Turitto, 1982). 
All these different experiments suggest that blood flow studies would be useful to 
understand vascular disease mechanisms, particularly in sickle cell disease, where 
RBCs could be implicated in tissular and cellular damages or vascular phenomenon as 
blood cell adhesion to endothelium. 
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In a previous study, using a dynamical approach with a flow chamber apparatus to 
simulate blood flow conditions, it was shown that velocity heterogeneity could be 
explained by RBC classification, leading to different RBC sub-groups (Allayous, Regis, 
Bruel, Schoevaert, Emilion, & Marianne-Pepin, 2007). Thus, the present study focuses 
on this particular RBC dynamic behavior according to vascular state and RBC 
morphology in order to simulate sickle cell disease inflammation and specific RBC 
structural dynamics and circulatory behaviors in a constant venular flow of 1 dyne/cm². 
 
 
2. Materiel and Methods 
 
2.1. TrHMEC culture 
 
Transformed Human Bone Marrow Endothelial Cells (TrHBMEC) were kindly 
provided by Pr. Elion and Dr. Weksler. They were maintained in humidified air/5% 
CO2 at 37°C. TrHBMEC monolayers were grown to confluence in gelatin-coated 
Thermanox slides (Nalgene Nunc International) as previously described by Schweitzer, 
et al. (1997). TrHBMEC subcultures at passage 17 were used for flow experiments, and 
cultures were examined prior to use to ensure confluence. 
 
2.2. Red blood cell (RBC) acquisition 
 
Peripheral venous blood samples were obtained from four healthy normal volunteers 
(AA) at the Centre National France Transplant (Hôpital Saint-Louis, Paris) and from 
four individuals with homozygous sickle cell disease (SS) that have not received any 
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medical treatment within the previous 15 days. RBCs were isolated from whole blood 
by repeated centrifugation and washed with saline. RBCs were suspended in TrHBMEC 
culture medium without fetal calf serum and adjusted to 106 red cells/ml for the flow 
assay. 
 
2.3. Flow assay protocol 
 
TrBMEC cultures were activated with culture medium containing pro-inflammatory 
cytokines: TNFα / IFNγ at 100 U/ml (Schweitzer et al. 1997) for 12, 24 or 48 hours 
prior to the start of a flow assay. Naïve TrHBMEC were sham-treated in an identical 
manner with culture medium alone (table 1). 
The cultured slides were secured to the flow chamber that is composed of a rectangular 
plexiglas cavity (0.2 mm height, 29 mm length, 5 mm width). The bottom wall of the 
chamber is a Thermanox coverslip (0.17 x 60 x 24 mm3) where endothelial cells were 
coated and directly in contact with RBCs. The cultured slides were mounted on an 
inverted-phase contrast microscope (Nikon Eclipse TE300, X20) equipped with a video 
camera. RBC suspension was then perfused through the chamber at 1 dyne/cm2, for 10 
minutes. The real-time images coming from the flow chamber (Figure 1) are recorded 
with a video tape recorder (Sony time lapse 168) and analyzed with a specific video 
analyzer (Pentium with Matrox digitized card). The experimental data obtained such as 
velocity, acceleration, angular deviation and linearity index, are used to characterize red 
cells trajectories, cell adhesion and cell-cell interactions. All experiments were 
performed at room temperature and repeated three times. 
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2.4. Classification methods 
 
Three classification methods were used, Hierarchical Agglomerative Clustering (HAC), 
K-Means clustering (K-Means) and Mixture of Gaussian distributions. 
 
2.4.1. HAC 
HAC is a hierarchical method based on hierarchical level of aggregation. The method 
provides increasing levels of classification. The visualization of the classification is 
made with a binary tree. 
 
2.4.2. K-Means 
K-Means is a classical method based on the evaluation of distances between the sample 
and the provided centers of classes which are given by the user at the beginning of the 
classification. These centers are then modified during the classification. 
 
The two methods gave different class centers. Number of classes and its centers are 
fixed beforehand in K-Means method while these parameters depend only on the level 
of classification chosen by the users in HAC method. 
 
2.4.3. Mixture of Gaussian distributions 
In order to classify the RBCs into N classes, with respect to their mean velocity value, 
we assume that these velocities are distributed as a mixture of Gaussian distributions 
p1f1(x) + …+ pNfN(x). Each number pi∈[0,1] represents the weight of class i, p1 +…+ pN  
= 1, and the distribution of the velocities within class i, say fi, is Gaussian with mean 
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and variance depending on i. The estimation of these parameters is done through a 
variant of the EM (Expectation Maximization) algorithm implemented in R language 
package (http://lib.stat.cmu.edu/R/CRAN). The R function Mclust ( ) yields the results, 
while the number of classes can be discussed by using a log-likelyhood criteria. 
 
The performance of each of these methods is evaluated by the number of RBCs in each 
class, the least mean variance and the greater distance between the different classes. The 
Gaussian mixture method often appears as the best one. 
 
2.5. Statistical analysis 
 
Data are presented as mean ± SE of the values obtained from independent experiments. 
Statistical analysis was performed using the single-factor analysis of variance 
(ANOVA) function in XLSTAT software to test for differences in RBC classes. 
Differences were considered to be statistically significant in cases in which the p value 
was less than or equal to 0.05 (representing a α = 0.05). 
 
3. Results 
 
The present study focuses on RBC mean velocity using a flow chamber associated to an 
apparatus of video-microscope image analyzer. This method simulates blood circulation 
in various conditions such as inflammation, medical treatment or vascular diseases 
where RBC dynamic and cell interactions are modified. The real-time images coming 
from the flow chamber are recorded and analyzed in order to determine each treatment 
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effect on RBC dynamic behavior. The purpose of the second part of this paper is to 
establish different RBC sub-groups using classification methods. 
 
This first part focuses on the general behavior of normal RBCs (AA) and sickle RBCs 
(SS) in various conditions (tables 1 and 2). 
 
3.1. General population mean velocity 
 
The different RBC mean velocities are summarized in table 2. 
 
3.1.1. Normal and sickle RBC general behavior 
 
AA and SS RBC general mean velocities (MVs) are respectively, 1005.94 ± 299.08 and 
1186.27 ± 264.89 µm/ms. In our conditions, SS RBCs seem to be significantly more 
rapid than AA RBCs. 
 
This preliminary result differs according to TrHBMEC treatment. Indeed, the nature and 
the time of this treatment both influence RBC evolution and profile in blood flow, as 
presented in next sections. 
 
3.1.2. Normal and sickle RBC general behavior under proinflammatory conditions 
 
TrHBMEC are activated by proinflammatory cytokines during 12, 24 or 48 hours (table 
1). 
 12
In case of a 12-hour treatment, AA RBC MV is significantly increased whereas SS RBC 
MV is similar when compared to basal conditions (table 2; fig. 2). 
AA RBC MV significantly decreases to normal MV when TrHBMEC are activated for 
24 hours (table 2; fig. 2). In parallel, SS RBC MV is significantly decreased to be 
similar than AA RBC MV in basal conditions (table 2; fig. 2). 
These MVs are not modified with a longer treatment (48-hour stimulation) (table 2; fig. 
2). 
Thus, proinflammatory treatment has different effects, according to RBC nature and 
stimulation time. 
 
RBC MV under a constant venular flow seems to depend on various parameters such as 
RBC nature, normal or sickle in our case and vascular environment, represented here by 
TrHBMEC treatment. Therefore, it would be interesting to consider each TrHBMEC 
treatment and its consequences for both RBC type. 
We can notice that proinflammatory cytokines treatment increases AA RBC MV after 
12 hours and decreases SS RBC MV after 24 hours (table 2; fig. 2). SS RBC behavior is 
different. Indeed, no effect is observed after a short treatment (12 hours). After a longer 
treatment (24 hours), proinflammatory cytokines modify this MV by increasing (table 2; 
fig. 2). 
Therefore, in addition to the relation between vascular environment and RBC behavior, 
this paper focuses on RBC heterogeneous responses and on the heterogeneity of this 
population. Indeed, those two opposed dynamic behaviors suggest that, in our 
experimental conditions under a constant venular flow, RBC MV should depend on 
various parameters such as RBC nature or vascular environment. On the other hand, we 
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may suppose that treatment effects are too weak to be significant when considering 
RBC general population. Therefore, it would be interesting to refine these preliminary 
results and determine whether or not there are different RBC sub-groups for each RBC 
type. If this hypothesis is true, we will focus on their responses in various vascular 
conditions and TrHBMEC treatments, in order to better understand the origin of these 
behaviors. This is the reason why we present, in the second part of this paper, an 
original idea of RBC classification to determine different RBC classes that would be 
responsible for population heterogeneity and behaviors already observed. In another 
way, we will try to see if the different TrHBMEC treatments have same effects on the 
different RBC sub-populations or classes, to generalize it for RBC dynamic behavior. 
 
3.2. RBC MV classification 
 
This study is based on the hypothesis that RBC velocity distribution should be a 
Gaussian one. Distribution represented in each condition is a mixture of two, three or 
even four Gaussian distributions, clearly showed in the different histograms built (data 
not shown). These observations confirm that RBC population is heterogeneous in each 
case. The different classification obtained will allow us to establish and characterize the 
different RBC dynamic behavior, with a constant flow and shear stress in the case of a 
normal and pathological vascular environment. 
 
3.2.1. Normal and sickle RBC classes 
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In an earlier article, HAC and K-Means methods lead us to classify AA RBCs into two 
classes (Allayous et al. 2007). Thanks to the Mixture of Gaussian distributions method, 
this result is refined in three classes. SS RBCs are divided in three classes also, as 
presented in table 3 and figure 3. 
We can notice that AA and SS are composed of three classes with different MVs. Thus, 
in class 1 and 2, SS RBC MV is significantly higher than AA RBC MV. In addition, 
RBC population is not equally distributed among the three classes. In class 1, there are 
as many AA RBCs as there are SS RBCs. On the contrary, in class 2, RBC number is 
higher and there are more AA RBCs than SS RBCs. However, there are twice as many 
SS RBCs as AA RBCs in class 3. 
 
3.2.2. Normal and sickle RBC behavior under proinflammatory conditions 
 
The different results presented in this section are summarized in table 4. AA RBCs are 
distributed into three classes under proinflammatory conditions, for each treatment time. 
Consequently, proinflammatory cytokines do not modify AA RBC class number. On the 
contrary, class distribution is modified according to treatment time. In addition, figure 4 
shows that time is an important parameter in AA RBC responses and velocity. We can 
notice that AA RBC MV significantly increases in each RBC sub-groups, after 12 hours 
(table 4; fig. 4). MV is significantly reduced after 24 hours in each case, but the biggest 
decrease is observed only for class 1 and 3, MV in class 2 shows no major differences 
with MV in basal conditions (table 4; fig. 4). Moreover, a little increase is observed 
only for class 1 MV after 48 hours, this class MV becomes similar to mean velocity 
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observed in basal conditions, whereas this value does not change for class 2 and 3 after 
a longer treatment (table 4; fig. 4). 
Proinflammatory conditions modify SS RBC behavior. Indeed, they are distributed into 
three classes when TrHBMEC are shortly stimulated (12 and 24 hours) and into two 
classes for longer treatment (48 hours), as presented in table 4. As observed for ASS 
RBCs, class distribution is modified according to treatment time. Figure 5 shows that 
SS RBC MV significantly increases after 12 hours only in class 2 and 3 whereas RBCs 
are more concentrated in class 2. Proinflammatory cytokines have a significant effect 
after 24 hours. Indeed, MV significantly decreases in the three classes, the most 
spectacular decrease is observed in class 1. In the same manner, RBC number in class 1 
and 3 decreases so as to be concentrated in class 2. This effect is reversed with a longer 
treatment where SS RBC MV significantly increases in the two classes and RBC are 
more concentrated in class 2. 
To conclude, we can notice that, in our experimental conditions, the same effect is 
observed on AA and SS RBC MV, after 24 hours. Actually, in each class, MV 
decreased concurrently with the number of red blood cells. However, we have noticed 
that class 2 contains the most RBCs and a greater amount of SS RBCs. 
 
 
4. Discussion 
 
 
The relation between blood cells, vascular environment and (vascular) tissues are of 
great importance in the circulatory function, particularly when considering RBC 
rheology. RBC behavior may depend on many factors such as age, cellular morphology, 
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density, deformability, blood flow, shear stress or vascular environment (molecules or 
disease state) (Armstrong, Wenby, Meiselman, & Fisher, 2004; Bishop, Popel, 
Intaglietta, & Johnson, 2001; Bransky, Korin, Nemirovski, & Dinnar, 2007; Grima, 
2007; Hardwicke & Squire, 1952; Kon, Maeda, & Shiga, 1987; Olshaker & Jerrard, 
1997; Pfafferott, Nash, & Meiselman, 1985; Watanabe, Kataoka, Yasuda, & Takatani, 
2006). 
All these notions such as inhibition of RBC deformability, increased RBC adhesion, 
blood flow abnormalities, vascular inflammation or abnormal cellular interactions are 
found in sickle cell disease (Bransky, Korin, Nemirovski, & Dinnar, 2007; Embury, 
Mohandas, Paszty, Cooper, & Cheung, 1999; Fink, Funahashi, Robinson, & Watson, 
1961; LaCelle, 1970; Lipowsky, Sheikh, & Katz, 1987; Lipowsky, 2005; Mohandas, 
Philips, & Bessis, 1979; Parthasarathi & Lipowsky, 1999; Paszty et al. 1997; Rodgers et 
al. 1984; Schmalzer, Manning, & Chien, 1989). 
Pointing out RBC heterogeneity in blood flow in order to establish velocity profiles, and 
understanding how these profiles are affected when endothelial cells are activated, are 
the two aspects that we have developed in this original study. 
 
We have already confirmed that AA RBCs are heterogeneous according to their velocity 
(Allayous, Regis, Bruel, Schoevaert, Emilion, & Marianne-Pepin, 2007; Rosenblum, 
1971; Rosenblum, 1972a; Rosenblum, 1972b; Rosenblum, 1976). This observation is 
also confirmed with SS RBCs. 
In addition, we have noticed that AA and SS are also heterogeneous even when vascular 
environment is different. Thus, AA and SS RBC classes and dynamic behavior for 
instance, evolve differently, according to endothelial state represented by nature and 
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time of TrHBMEC treatment. This heterogeneity seems to reflect RBC position in the 
flow. Thus, the fastest cells are more into an axial migration in the flow and the slowest 
ones are closer to the vascular wall (Bishop, Popel, Intaglietta, & Johnson, 2001). 
However, the flow chamber apparatus used in this study does not allow us to confirm 
these positions, in a constant venular flow and a constant hematocrit. 
These different RBC velocity and class heterogeneities must be explained by RBC 
nature, endothelial cell activation or state, and also by the different cellular interactions 
occurring in the blood flow. It is important to notice that in all of the experiments, 
RBCs were perfused with a particular medium in order to minimize undesirable 
interactions due to system contamination (plasma proteins, etc…). 
RBC nature and dynamic behavior, also known as RBC rheology, includes cellular 
deformability, intracellular viscosity, flow and shear stress, aggregation, RBC density 
and age, for example (Armstrong, Wenby, Meiselman, & Fisher, 2004; Fischer & 
Schmid-Schönbein, 1977; Fischer, Schmid-Schönbein, & Stöhr-Liesen, 1978a; Fischer, 
Stöhr, & Schmid-Schönbein, 1978b; Grima, 2007; Kon, Maeda, & Shiga, 1987; 
Pfafferott, Nash, & Meiselman, 1985; Schmid-Schönbein & Wells. 1969; Watanabe, 
Kataoka, Yasuda, & Takatani, 2006). 
Here, RBC heterogeneity, expressed as an increase, a stabilization or a decrease in RBC 
velocity, could be explained by different notions that will be developed in the following 
sections. 
In normal conditions, RBCs have many cellular properties explaining their particular 
rheology, like their deformability, their aggregability and their adhesion to endothelial 
cells (Barshtein, Ben-Ami, & Yedgar, 2007). All experiments were performed with 
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controlled venular flow and shear stress (1 dyne/cm²) as well as a constant hematocrit, 
and do not interfere with RBC velocity. 
SS RBCs have particular cellular properties such as a decrease in deformability, leading 
to vascular blockage, a decrease in cellular aggregability and an increase in cellular 
adhesion (Barshtein, Ben-Ami, & Yedgar, 2007; Bransky, Korin, Nemirovski, & 
Dinnar, 2007; Dhermy, Simeon, Wautier MP, Boivin, & Wautier JL, 1987; Finnegan, 
Turhan, Golan, & Barabino, 2007; Hebbel, 1997; Hebbel, 1997; Kaul, Nagel, Chen, & 
Tsai, 1993; Mchedlishvili, 1998; Mohandas & Chasis, 1993; Parthasarathi & Lipowsky, 
1999; Wick & Eckman, 1996). These factors trigger abnormal blood flow (Embury, 
Mohandas, Paszty, Cooper, & Cheung, 1999; Fink, Funahashi, Robinson, & Watson, 
1961; Lipowsky, Sheikh, & Katz, 1987; Paszty et al., 1997; Rodgers, Schechter, 
Noguchi, Klein, Nienhuis, & Bonner, 1984) and abnormal red blood cell velocities, as 
observed in the present study. 
These RBC properties are combined with vascular environment, represented by 
endothelial cell activation. 
TrHBMEC were activated by proinflammatory cytokines (Schweitzer et al., 1997). 
It is well-known that endothelial cells are activated by pro-inflammatory cytokines. This 
activation is translated by cell-surface adhesion molecule expression and regulation. 
TrHBMEC is a well-characterized cell line that expresses all endothelial markers such 
as von Willebrand factor, Vascular Cell 1dhesion Molecule-1 (VCAM-1), InterCellular 
Adhesion Molecule-1 (ICAM-1), E-selectine or P-selectine (Schweitzer et al., 1997). 
It has been recently shown that ICAM-1 expression and release are increased in the 
presence of cytokines during 48 hours (Brun, Bourdoulous, Couraud, Elion, 
Krishnamoorty, & Lapouméroulie, 2003; Schweitzer et al., 1997). In addition, VCAM-1 
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expression is induced by cytokines, the most important expression is observed between 
12 and 24 hours, without affecting its release (Brun, Bourdoulous, Couraud, Elion, 
Krishnamoorty, & Lapouméroulie, 2003; Schweitzer et al., 1997). The level of soluble 
ICAM-1 reflects the degree of inflammation and endothelial cell activation (Gearing & 
Newman, 1993). SS RBCs have been shown to induce ICAM-1 expression by 
endothelial cells in culture and flow studies (Brun, Bourdoulous, Couraud, Elion, 
Krishnamoorty, & Lapouméroulie, 2003; Shiu, Udden, & McIntire, 2000). 
VCAM-1 expression is up-regulated by proinflammatory cytokines and is the receptor 
of the very late antigen-4 (VLA-4) expressed on SS RBCs (Elion & Labie, 1998; Gee & 
Platt, 1995; Joneckis, Ackley, Orringer, Wayner, & Parise, 1993; Stuart & Nagel, 2004; 
Swerlick, Eckman, Kumar, Jeitler, & Wick, 1993). 
These molecular modifications could contribute to clinical observations such as a 
decrease in vascular occlusion in sickle cell patients. 
 
These notions linked to RBC nature could be useful to understand the physiological 
meaning of the heterogeneity of RBC velocities and the different velocity profiles. 
Moreover, cellular adhesion, represented by cell-surface molecules and RBC 
deformability, also participate in this phenomenon. In addition, it has been shown that 
SS RBC perfusion increases the expression of cell adhesion molecules on endothelial 
cells, such as ICAM-1 and VCAM-1, and stimulates the release of soluble cell adhesion 
molecules, which may serve as indicators of injury and/or activation of endothelial cells 
(Shiu, Udden, & McIntire, 2000). The interactions between sickle red blood flow, 
inflammatory cytokines, and vascular adhesion events may render sickle cell disease 
patients vulnerable to vasoocclusive crises (Shiu, Udden, & McIntire, 2000). 
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Another aspect of this work would consist in linking RBC velocity to RBC trajectory in 
order to characterize particular RBCs and molecular profiles, according to vascular state 
(inflammation, drugs, …). 
 
Inflammation state is very important in sickle cell disease. In fact, sickle RBCs are more 
adherent to vascular endothelium and the endothelium in sickle cell patients is inflamed 
(Duits et al., 1996; Solovey, Lin, Browne, Choong, Wayner, & Hebbel, 1997; Turhan, 
Jenab, Bruhns, Ravetch, Coller, & Frenette, 2004). 
It would help to have a better understanding of RBC dynamics, particularly by knowing 
what are the differences between sub-populations at a molecular level, like young 
RBCs, their density, the expression of cell-surface molecules, etc…. All these questions 
could be answered thanks to different experiments such as blocking molecules at the 
surface of endothelial cells, perfusing with different categories of RBCs (young, dense, 
etc…), so as to understand the physiological meaning of such an heterogeneity better. 
Moreover, this study would give us a better knowledge of the complex vascular 
occlusion pathway and also of red blood cell rehology and effects in normal vascular 
function in order to apply it to pathological mechanisms. 
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6. Tables 
 
TrHBMEC treatment    AA RBCs   SS RBCs 
None 
TNFα: 100 U/ml / IFNγ: 100 U/ml  12h    12h 
  24h    24h 
      48h    48h 
 
 
Table 1: TrHBMEC treatments before flow assay. 
RBCs, Red blood cells. 
 33
 
 
RBCs  Treatment  Time  MV (µm/ms)   RBC N 
AA  None     1005.94 ± 299.08  58 
Cytokines  12h  1219.34 ± 421.83  63 
24h  1025.49 ± 357.83  60 
48h  1004.67 ± 308.06  62 
SS  None     1186.27 ± 264.89  58 
Cytokines  12h  1167.59 ± 306.55  60 
24h  913.88 ± 307.44  61 
48h  876.97 ± 282.37  60 
 
 
Table 2: AA and SS RBC general mean velocities after TrHBMEC treatment. 
MV, Mean velocity; RBC, Red blood cell; RBC N, Red blood cell number 
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RBCs   Class   MV (µm/ms)   RBC % 
AA   1   709.84 ± 83.98  29 
2   1031.85 ± 153.32  59 
3   1599.22 ± 196.99  12 
SS   1   901.95 ± 91.16  31 
2   1175.54 ± 86.61  45 
3   1571.77 ± 100.83  24 
 
 
Table 3: AA and SS RBC classes when TrHBMEC are not treated. 
MV, Mean velocity; RBC, Red blood cell 
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RBCs  Time  Class  MV (µm/ms)   RBC % 
AA  12h  1  868.68 ± 161.12  45 
2  1262.14 ± 92.16  25 
    3  1746.05 ± 220.54  30 
24h  1  542.78 ± 117.61  27 
    2  947.12 ± 81.58  30 
    3  1350.64 ± 198.03  43 
  48h  1  774.51 ± 123.85  52 
    2  1020.22 ± 12.47  16 
    3  1365.14 ± 231.22  32 
SS  12h  1  829.33 ± 116.37  35 
    2  1272.66 ± 112.67  53 
    3  1702.09 ± 143.87  12 
  24h  1  336.81 ± 115.58  13 
    2  918.49 ± 137.62  71 
3  1355.74 ± 135.35  16 
48h  1  533.79 ± 121.59  32 
    2  1036.01 ± 170.56  68 
 
Table 4: AA and SS RBC sub-groups when TrHBMEC are stimulated with 
proinflammatory cytokines during 12; 24 and 48 hours before flow assay. 
MV, Mean velocity; RBC, Red blood cell 
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7. Figures 
 
 
 
 
 
Figure 1: RBC and TrHBMEC interactions under venular blood flow. 
A
t = 0 µs
TrHBMEC TrHBMEC
RBC
B
t = 20 µs
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Figure 2: Mean velocity of total AA and SS RBC population when TrHBMEC are 
stimulated by proinflammatory cytokines during 12, 24 and 48 hours before flow assay. 
* p ≤ 0.05 vs. AA (0; 12; 24; 48h); # p ≤ 0.05 vs. SS (0; 12; 24; 48h). 
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Figure 3 : Evolution of mean velocities of AA and SS RBC classes in basal conditions 
(TrHBMEC are not activated). 
* p ≤ 0.05 vs. AA. Histogram width reflects the percentage of RBCs in each class. 
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Figure 4 : Evolution of mean velocities of AA RBC classes when TrHBMEC are 
activated by proinflammatory cytokines during 12, 24 and 48 hours before flow assay. 
* p ≤ 0.05 vs. AA (0; 12; 24; 48h). Histogram width reflects the percentage of RBCs in 
each class. 
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Figure 5 : Evolution of mean velocities of SS RBC classes when TrHBMEC are 
activated by proinflammatory cytokines during 12, 24 and 48 hours before flow assay. 
#
 p ≤ 0.05 vs. Basal SS (0; 12; 24; 48h). Histogram width reflects the percentage of 
RBCs in each class. 
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